Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy

January 21, 2025 updated by: Zia, Al Raza
We are studying & researching the effect of CranioSacral Integrative therapy on Parkinson's Diseased Patients for 3 months. With a therapeutic induction via manual CranioSacral integrative therapy for 90 minutes per session with a total of 2 session divided equally in a month (biweekly intervention). At the end of 3 months each patient will have total of 9 hours of CranioSacral Integrative therapy induced, we will document the symptoms and shortcomings of the patients at evaluation, before and after therapeutic treatment on a measured scale ranging from 1-10. Finally graphically and statistically measure the quality of change in the symptoms at the end of 3 months and provide executive summary of the research finding, which the investigators expect to be a positive one.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

We are studying & researching the effect of CranioSacral I therapy on Parkinson's Disease

Study Type

Interventional

Enrollment (Estimated)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Michigan
      • Ann Arbor, Michigan, United States, 48104
        • Naturalmed therapy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • must be Diagnosed with Parkinson's Disease

Exclusion Criteria:

  • Anyone without Parkinson's Disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: biweekly intervention
Other: biweekly intervention
10 step craniosacral therapy protocol through manual therapy at feet , thoracic diaphragm, neck and cranium
Other Names:
  • manual therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
reduction in tremors due to Parkinson's disease in the patient
Time Frame: 3 months
Measurement of the tremors and quality of the coordination of the medial leminiscus system on 1-10 (1 being zero tremors and 10 being out of control tremors) scale at the evaluation and at beginning and at the end of each treatment session and in the end will provide a graphical and statistical display in the change in the tremors relative to the therapeutic induction
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of Proprioception
Time Frame: 3 months
will evaluate the patients ability to move within space and time with certain precision and measure it on a scale of 1-10 (1 being very precise with fine motor movement and 10 being out of control fine motor movements)at the time of evaluation and at the beginning and end of each therapeutic treatment and finally document it graphically and statistically, the change in the overall motor movements like walking and quality of gait.
3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall emotional State and sleep quality
Time Frame: 3 months
will evaluate the overall emotional and sleeping habits on the measurement scale of 1-10 where 1 being emotionally stable and positive with 8 hours of quality sleep and 10 being emotionally unstable and have less than 4 hours of sleep at night and at the end of research will graphically and statistically provide the outcome of the above mentioned measure.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Zia, Al Raza

Investigators

  • Principal Investigator: Al Raza, CST, IBR, Inc.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2014

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

March 1, 2025

Study Registration Dates

First Submitted

November 14, 2013

First Submitted That Met QC Criteria

November 19, 2013

First Posted (Estimated)

November 20, 2013

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 21, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CST001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson's Disease

Clinical Trials on biweekly intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe